Is Short-Term ADT Good Enough in High-Risk Prostate Cancer? Is Short-Term ADT Good Enough in High-Risk Prostate Cancer?
Continuing ADT beyond 6 months does not improve outcomes in men with high-risk localized prostate cancer also receiving brachytherapy and external beam radiation therapy, new research suggests.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Brachytherapy | Cancer | Cancer & Oncology | External Beam Therapy | Hematology | Prostate Cancer | Radiation Therapy